Raman Bahal
Associate Professor/Pharmaceutical Science

Are you Raman Bahal?

How to update your information.
Targeting genomic DNA for cancer therapy, Invention disclosure submitted
2023
Research Type: Patent and Intellectual Property

Discoidal nano universal platform for efficient delivery of PNAs
2023
Research Type: Patent and Intellectual Property

Dual-modality poly-L-histidine nanoparticles to deliver peptide nucleic acids and paclitaxel for in vivo cancer therapy
2022
Research Type: Patent and Intellectual Property

Microrna-33 inhibitors and use thereof in the treatment of pulmonary fibrosis” Provisional patent
2022
Research Type: Patent and Intellectual Property

Composition of tunable carbohydrate nucleic acid conjugates for enhanced liver and kidney-specific targeting
2022
Research Type: Patent and Intellectual Property

PLA-HPG particles delivered multiple oncomiRs inhibitors for cancer treatment
2021
Research Type: Patent and Intellectual Property

Next generation microRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticle
2020
Research Type: Patent and Intellectual Property

Discoidal Nano Universal Platform for Efficient Delivery of PNAs for gene therapy based application
2019
Research Type: Patent and Intellectual Property